Charpentier/Doudna Patent Covering CRISPR-Cas9 Gene Regulation Applications – Business Wire (press release)
Business Wire (press release) |
Charpentier/Doudna Patent Covering CRISPR-Cas9 Gene Regulation Applications
Business Wire (press release) DUBLIN–(BUSINESS WIRE)–ERS Genomics announced today that the European Patent Office (EPO) has granted Dr. Emmanuelle Charpentier, ERS Genomics' co-founder, together with the University of California and University of Vienna, its second EU patent with … |
